Proleukin interleukin-2 data

Use of CHIR's IL-2 on an intermittent basis complemented anti-retroviral therapy and stimulated a rise in CD4 counts in HIV-infected people, according to

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE